These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11459012)

  • 1. Induction of immune responses to glycoprotein gD of Aujeszky's disease virus with DNA immunization.
    Hwang DY; Lee JB; Kim TJ; Song JY; Hyun BH; Song CS; Park SY
    J Vet Med Sci; 2001 Jun; 63(6):659-62. PubMed ID: 11459012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunological characteristics of Aujeszky's disease virus glycoprotein].
    Vrublevskaia VV; Musienko VS; Skarga IuIu; Morenkov OS
    Vopr Virusol; 2007; 52(3):33-7. PubMed ID: 17601050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of pigs against Aujeszky's disease by DNA vaccination.
    Gerdts V; Jöns A; Makoschey B; Visser N; Mettenleiter TC
    J Gen Virol; 1997 Sep; 78 ( Pt 9)():2139-46. PubMed ID: 9291999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA priming and killed virus boosting vaccination strategy can augment the immune response to pseudorabies virus.
    Chen ZH; Guo X; Ge XN; Jia H; Yang HC
    Acta Virol; 2007; 51(3):163-70. PubMed ID: 18076306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aujeszky's disease vaccination and infection of pigs with maternal immunity: effects on cell- and antibody-mediated immunity.
    Wittmann G; Ohlinger V
    Arch Virol; 1987; 92(1-2):87-101. PubMed ID: 3026291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical porcine circovirus type 2 infection does not modulate the immune response to an Aujeszky's disease virus vaccine.
    Díaz I; Cortey M; Darwich L; Sibila M; Mateu E; Segalés J
    Vet J; 2012 Oct; 194(1):84-8. PubMed ID: 22464756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of mice from lethal infection with Aujeszky's disease virus by immunization with purified gVI.
    Ishii H; Kobayashi Y; Kuroki M; Kodama Y
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1411-4. PubMed ID: 2838579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay.
    van Oirschot JT; Rziha HJ; Moonen PJ; Pol JM; van Zaane D
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1179-82. PubMed ID: 3011974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two ELISAs for detecting antibodies to glycoprotein I of Aujeszky's disease virus.
    Van Oirschot JT; Oei HL
    Vet Rec; 1989 Jul; 125(3):63-4. PubMed ID: 2549677
    [No Abstract]   [Full Text] [Related]  

  • 10. A vector DNA vaccine encoding pseudorabies virus immediate early protein demonstrates partial protection in mice against lethal virus challenge.
    Chang SW; Bu J; Rompato G; Garmendia AE
    Viral Immunol; 1998; 11(1):27-36. PubMed ID: 9586695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different prime-boost regimes with DNA and recombinant Orf virus based vaccines expressing glycoprotein D of pseudorabies virus in pigs.
    van Rooij EM; Rijsewijk FA; Moonen-Leusen HW; Bianchi AT; Rziha HJ
    Vaccine; 2010 Feb; 28(7):1808-13. PubMed ID: 20018271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local humoral and cellular responses in Aujeszky's disease virus infection in pigs.
    Martin S; Wardley RC
    Res Vet Sci; 1987 Mar; 42(2):170-4. PubMed ID: 3035662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunobiology of pseudorabies (Aujeszky's disease).
    Mettenleiter TC
    Vet Immunol Immunopathol; 1996 Nov; 54(1-4):221-9. PubMed ID: 8988868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinction between Aujeszky's disease virus-infected and vaccinated pigs by hemagglutination-inhibition test.
    Shibata I; Uruno K; Samegai Y; Inaba Y
    J Vet Med Sci; 1993 Oct; 55(5):859-61. PubMed ID: 8286546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal and systemic immune responses to Aujeszky's disease virus (ADV) in early vaccinated piglets.
    Salinas-Zacarias I; Guzman-Bautista ER; Ramírez-Estudillo MDC; Chacón-Salinas R; Vega-López MA
    Comp Immunol Microbiol Infect Dis; 2020 Feb; 68():101400. PubMed ID: 31794953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of wild type Aujeszky's disease virus in swine identified as subclinical low-prevalent serological test reactors within qualified virus-negative herds.
    Scherba G; Jin L
    Vet Microbiol; 1994 Jun; 40(3-4):335-49. PubMed ID: 7941297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma secretion and proliferative responses of peripheral blood mononuclear cells after vaccination of pigs against Aujeszky's disease in the presence of maternal immunity.
    Pomorska-Mól M; Markowska-Daniel I
    FEMS Immunol Med Microbiol; 2010 Apr; 58(3):405-11. PubMed ID: 20180849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal vaccination of pigs against Aujeszky's disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres.
    Van Oirschot JT
    Res Vet Sci; 1987 Jan; 42(1):12-6. PubMed ID: 3029845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL
    Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formaldehyde-fixed cells infected with pseudorabies virus conferred resistance against Aujeszky's disease.
    Tanaka S; Imamura T; Matsui H; Sakaguchi M; Matsuo K; Yamamoto M
    J Vet Med Sci; 1994 Dec; 56(6):1177-9. PubMed ID: 7696414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.